Optimal neoadjuvant chemotherapy duration in Wilms tumour with intravascular thrombus: A literature review and evidence from SIOP WT 2001 trial.
Louise MorrisRoly SquireBeata SznajderHarm van TinterenJan GodzinskiMark PowisPublished in: Pediatric blood & cancer (2019)
There is no evidence that prolonged courses of neoadjuvant chemotherapy beyond the recommended protocols confer any additional benefit in treating intravascular extension of Wilms tumour.